Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancer
The use of nacVI-RADS can predict pCR after NAC with high specificity but low sensitivity and a high inter-observer agreement. A 3-step score adds value in determining local residual disease, rCR assessed by this method could correlate with DFS benefit. mpMRI scores should be prospectively assessed in future trials of multimodal management of MIBC and can be a predictive asset in routine clinical management.
Authors
- Geert Villeirs (ORCID: https://orcid.org/0000-0002-9073-3341)
- Mats Van den Broecke (ORCID: https://orcid.org/0000-0001-9713-8564)
- Alexander Decruyenaere (ORCID: https://orcid.org/0000-0001-6795-7606)
- Daan De Maeseneer (ORCID: https://orcid.org/0000-0002-0339-5621)
- Charles Van Praet (ORCID: https://orcid.org/0000-0002-4467-0829)
- Sylvie Rottey (ORCID: https://orcid.org/0000-0003-2060-3725)
- Pieter De Visschere (ORCID: https://orcid.org/0000-0002-4842-7877)
- Valérie Fonteyne (ORCID: https://orcid.org/0000-0001-6724-1595)
- Karel Decaestecker (ORCID: https://orcid.org/0000-0003-0767-940X)
- Felix Delbare (ORCID: https://orcid.org/0000-0001-5890-7113)
- Sofie Verbeke (ORCID: https://orcid.org/0000-0002-5402-8581)
Institutions
- Ghent University Hospital (BE)
- AZ Sint-Lucas (BE)
- AZ Maria Middelares (BE)
- AZ Sint-Lucas (BE)
Publication Details
- Journal
- BMC Medical Imaging
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1186/s12880-024-01441-y
- Citations
- 3
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.72